Skip to content
10-Q

Quarterly Report

CEREBAIN BIOTECH CORP.

0001477932-17-005428

← back to feed
Filed
Nov 9, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · Nov 9, 2017 8.32M sh
Stockholders Equity Q1 2018 · Sep 30, 2017 −$4.52M
Stockholders Equity Q1 2018 · Jun 30, 2017 −$4.25M
Current Liabilities Q1 2018 · Sep 30, 2017 $1.91M
Current Liabilities Q1 2018 · Jun 30, 2017 $1.75M
Total Liabilities Q1 2018 · Sep 30, 2017 $4.66M
Total Liabilities Q1 2018 · Jun 30, 2017 $4.49M
Current Assets Q1 2018 · Sep 30, 2017 $139.19K
Current Assets Q1 2018 · Jun 30, 2017 $236.86K
Total Assets Q1 2018 · Sep 30, 2017 $139.19K
Total Assets Q1 2018 · Jun 30, 2017 $236.86K
Operating Income Q1 2018 · Sep 30, 2017 −$431.48K
Operating Income Q1 2018 · Sep 30, 2016 −$4.19M
Operating Cash Flow Q1 2018 · Sep 30, 2016 −$198.66K
Cash And Equivalents Q1 2018 · Sep 30, 2016 $1.58K
Cash And Equivalents Q1 2018 · Jun 30, 2016 $20.25K
Sga Expense Q1 2018 · Sep 30, 2016 $390.1K
Rd Expense Q1 2018 · Sep 30, 2016 $69.9K
Net Income Q1 2018 · Sep 30, 2016 −$4.19M